[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Publications found: 32,877
Sort by:

Advanced Renal Cell Carcinoma - Pipeline Insight, 2021

US$ 2,500.00

This report can be delivered to the clients within 3-5 business days DelveInsight’s, “Advanced Renal Cell Carcinoma - Pipeline Insight, 2021,” report provides comprehensive insights about 40+ compan...

September 2021 60 pages

Behзet’s syndrome - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Behзet’s syndrome - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline dr...

September 2021 60 pages

Complicated Urinary Tract Infections - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Complicated Urinary Tract Infections – Pipeline Insight, 2021,” report provides comprehensive insights about 12+ compa...

September 2021 60 pages

Congenital Adrenal Hyperplasia - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Congenital Adrenal Hyperplasia – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5...

September 2021 60 pages

Erosive esophagitis - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 24 hours DelveInsight’s, “Erosive esophagitis - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline...

September 2021 60 pages

Facioscapulohumeral Muscular Dystrophy - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Facioscapulohumeral Muscular Dystrophy – Pipeline Insight, 2021,” report provides comprehensive insights about 8+ comp...

September 2021 60 pages

Familial Lipoprotein Lipase Deficiency – Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 24 hours DelveInsight’s, “Familial Lipoprotein Lipase Deficiency - Pipeline Insight, 2021,” report provides comprehensive insights about 7+ compani...

September 2021 60 pages

Generalized Anxiety Disorder - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Generalized Anxiety Disorder – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and...

September 2021 60 pages

Heart failure with preserved ejection fraction (HFpEF)

US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Heart failure with preserved ejection fraction (HFpEF) - Pipeline Insight, 2021,” report provides comprehensive insights...

September 2021 60 pages

Heart Failure With Reduced Ejection Fraction (HFrEF)

US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Heart Failure With Reduced Ejection Fraction (HFrEF) - Pipeline Insight, 2021,” report provides comprehensive insights ab...

September 2021 60 pages

Kidney Transplant Rejection - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 2-3 business days DelveInsight’s, “Kidney Transplant Rejection – Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companie...

September 2021 60 pages

Leber congenital amaurosis - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Leber congenital amaurosis - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+...

September 2021 60 pages

Lung transplant rejection - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Lung transplant rejection - Pipeline Insight, 2021,” report provides comprehensive insights about 7+ companies and 7+ pip...

September 2021 60 pages

Meibomian Gland Dysfunction - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Meibomian Gland Dysfunction – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 8...

September 2021 60 pages

Myositis - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 3-5 business days DelveInsight’s, “Myositis - Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 15+ pipeline...

September 2021 60 pages

Nephrotic syndrome - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Nephrotic syndrome - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline d...

September 2021 60 pages

Niemann-Pick Type C Disease - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Niemann-Pick Type C Disease – Pipeline Insight, 2021,” report provides comprehensive insights about 13+ companies and...

September 2021 60 pages

Peripheral nerve injuries - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Peripheral nerve injuries - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ p...

September 2021 60 pages

Proliferative vitreoretinopathy - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Proliferative vitreoretinopathy - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and...

September 2021 60 pages

Rabies infection - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48-72 hours DelveInsight’s, “Rabies infection – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipelin...

September 2021 60 pages

Ragweed pollen hypersensitivity - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Ragweed pollen hypersensitivity - Pipeline Insight, 2021,” report provides comprehensive insights about 2+ companies and...

September 2021 60 pages

Schizoaffective Disorder - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Schizoaffective Disorder – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipe...

September 2021 60 pages

Sturge-Weber Syndrome - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Sturge-Weber Syndrome – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipelin...

September 2021 60 pages

Toll-like-receptor-agonists - Pipeline Insight, 2021

US$ 2,500.00

This report can be delivered to the clients within 3-4 working days DelveInsight’s, “Toll-like-receptor-agonists - Pipeline Insight, 2021,” report provides comprehensive insights about 35+ companies...

September 2021 100 pages

Ulcerative proctitis - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Ulcerative proctitis - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline...

September 2021 60 pages

Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1) - Drugs In Development, 2021

US$ 3,500.00

Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1) - Drugs In Development, 2021 SUMMARY Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1) pipeline Target constitutes c...

August 2021 28 pages

Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) - Drugs In Development, 2021

US$ 3,500.00

Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) - Drugs In Development, 2021 SUMMARY Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) - Catheps...

August 2021 36 pages

Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Drugs In Development, 2021

US$ 3,500.00

Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Drugs In Development, 2021 SUMMARY According to the recently published report 'Coagulation Factor XI - Drugs In Develo...

August 2021 80 pages

Estrogen Receptor Beta - Drugs In Development, 2021

US$ 3,500.00

Estrogen Receptor Beta - Drugs In Development, 2021 SUMMARY According to the recently published report 'Estrogen Receptor Beta - Drugs In Development, 2021'; Estrogen Receptor Beta (ER Beta or Nuclear...

August 2021 77 pages

Gamma Secretase (EC 3.4.23.) - Drugs In Development, 2021

US$ 3,500.00

Gamma Secretase (EC 3.4.23.) - Drugs In Development, 2021 SUMMARY According to the recently published report 'Gamma Secretase - Drugs In Development, 2021'; Gamma Secretase (EC 3.4.23.) pipeline Targe...

August 2021 87 pages

Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) - Drugs In Development, 2021

US$ 3,500.00

Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) - Drugs In Development, 2021 SUMMARY Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) pipeline Target constitutes close to 8 mole...

August 2021 81 pages

Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Drugs In Development, 2021

US$ 3,500.00

Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Drugs In Development, 2021 SUMMARY According to the recently published report 'Histone Deacetylase 1 - Drugs In Development, 2021'; Histone Deacetylase 1...

August 2021 191 pages

Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) - Drugs In Development, 2021

US$ 3,500.00

Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) - Drugs In Development, 2021 SUMMARY Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) pipeline Target constitutes close...

August 2021 124 pages

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Drugs In Development, 2021

US$ 3,500.00

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Drugs In Development, 2021 SUMMARY Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or H...

August 2021 154 pages

Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Drugs In Development, 2021

US$ 3,500.00

Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) - Drugs In Development, 2021 SUMMARY Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PG...

August 2021 113 pages

Retinoic Acid Receptor Alpha - Drugs In Development, 2021

US$ 3,500.00

Retinoic Acid Receptor Alpha - Drugs In Development, 2021 SUMMARY Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) pipeline Target constitutes...

August 2021 76 pages

Retinoic Acid Receptor Gamma - Drugs In Development, 2021

US$ 3,500.00

Retinoic Acid Receptor Gamma - Drugs In Development, 2021 SUMMARY Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) - Retinoic acid receptor ga...

August 2021 88 pages

Adrenocortical Carcinoma (Adrenal Cortex Cancer) (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Adrenocortical Carcinoma (Adrenal Cortex Cancer) (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Adrenocortical Carc...

August 2021 416 pages

Allergic Conjunctivitis (Ophthalmology) - Drugs In Development, 2021

US$ 2,000.00

Allergic Conjunctivitis (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Allergic Conjunctivitis - Drugs In Deve...

August 2021 132 pages

Asthma (Respiratory) - Drugs In Development, 2021

US$ 2,500.00

Asthma (Respiratory) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Asthma - Drugs In Development, 2021, provides an overview...

August 2021 931 pages

Atherosclerosis (Cardiovascular) - Drugs In Development, 2021

US$ 2,000.00

Atherosclerosis (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atherosclerosis - Drugs In Development, 2021,...

August 2021 276 pages

Basal Cell Carcinoma (Basal Cell Epithelioma) (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Basal Cell Carcinoma (Basal Cell Epithelioma) (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Basal Cell Carcinoma -...

August 2021 545 pages

Behcet Disease (Cardiovascular) - Drugs In Development, 2021

US$ 2,000.00

Behcet Disease (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Behcet Disease - Drugs In Development, 2021, pr...

August 2021 72 pages

Bone Metastasis (Oncology) - Drugs In Development, 2021

US$ 2,000.00

Bone Metastasis (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bone Metastasis - Drugs In Development, 2021, provid...

August 2021 106 pages

Bronchiectasis (Respiratory) - Drugs In Development, 2021

US$ 2,000.00

Bronchiectasis (Respiratory) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bronchiectasis - Drugs In Development, 2021, provi...

August 2021 123 pages

Cataract (Ophthalmology) - Drugs In Development, 2021

US$ 2,000.00

Cataract (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cataract - Drugs In Development, 2021, provides an ove...

August 2021 46 pages

Chikungunya Fever (Infectious Disease) - Drugs In Development, 2021

US$ 2,000.00

Chikungunya Fever (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chikungunya Fever - Drugs In Development...

August 2021 155 pages

Chronic Obstructive Pulmonary Disease (COPD) (Respiratory) - Drugs In Development, 2021

US$ 2,500.00

Chronic Obstructive Pulmonary Disease (COPD) (Respiratory) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Obstructive...

August 2021 675 pages

Corneal Neovascularization (Ophthalmology) - Drugs In Development, 2021

US$ 2,000.00

Corneal Neovascularization (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Corneal Neovascularization - Drugs I...

August 2021 47 pages

Critical Limb Ischemia (Cardiovascular) - Drugs In Development, 2021

US$ 2,000.00

Critical Limb Ischemia (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Critical Limb Ischemia - Drugs In Devel...

August 2021 163 pages

Filters

Search

Categories

23,409
8,495
40
23
910

Publishers

72
1
292
33
6
72
4
18
50
16
3
112
30
34
6,128
13
120
12
142
51
363
8
25
84
33
8
8
14
6
49
111
7
1
1,818
10
579
11
2,786
7
24
5,307
44
31
54
216
1,098
40
32
7
37
46
43
50
2,538
208
40
26
7
6
2
4
33
15
596
3,346
2,222
11
22
1
16
38
228
2
7
10
4
79
4
26
50
1
5
6
2
2
32
2
13
17
1
11
106
36
1
18
181
172
4
2
1
5
4
9
78
12
27
50
33
1
27
27
1
2
1
42
55
14
18
1
323
877
571
2
1
2
5
88
74
59
37
41
22
2
14
5
22
2
2

Regions

14
13
12
11
11
7
6
5
3
2
1
1,371
100
87
57
55
54
52
33
31
29
28
26
25
24
23
23
23
22
22
21
20
20
20
20
19
19
19
19
19
19
19
19
18
18
18
18
17
17
17
16
16
16
16
15
15
15
15
13
12
11
11
11
10
10
7
5
7
4
13
5
10
8
28
1,612
17
741
21
19
14
1,325
700
597
31
30
7
6
6
5
5
4
5
5
5
4
3
1
1
1
1
10
2
4
2
2
689
16
14
4
46
12
6
57
7
24,000

Price

Date

Pages

Offers

16
15
44
5
1
2